Advances in endobariatrics: past, present, and future.
Abhishek ShenoyAllison R SchulmanPublished in: Gastroenterology report (2023)
The obesity epidemic in the USA and worldwide is well documented and continues to grow. Endoscopic metabolic and bariatric therapies may offer a less invasive approach than surgical intervention. This article will review advances in endobariatrics over the last several decades, addressing the past and current state of bariatric and metabolic endoscopy. Food and Drug Administration-cleared devices and interventions currently under investigation are described including gastric devices, gastric remodeling procedures, small-bowel devices, duodenal ablation, as well as procedures to address weight regain after bariatric surgery. Future studies evaluating gastric and duodenal combination therapy, adjunctive pharmacotherapy, as well as individualized precision-health algorithms are underway.
Keyphrases
- weight loss
- small bowel
- combination therapy
- gastric bypass
- roux en y gastric bypass
- drug administration
- bariatric surgery
- physical activity
- healthcare
- randomized controlled trial
- weight gain
- public health
- machine learning
- metabolic syndrome
- type diabetes
- insulin resistance
- mental health
- body mass index
- current status
- ultrasound guided
- deep learning
- health information
- social media
- skeletal muscle
- high fat diet induced
- atrial fibrillation
- adipose tissue